Cargando…
Cannabinoids Inhibited Pancreatic Cancer via P-21 Activated Kinase 1 Mediated Pathway
The anti-cancer effects of cannabinoids including CBD (Cannabidiol) and THC ((−)-trans-∆9-tetrahydrocannabinol) have been reported in the case of pancreatic cancer (PC). The connection of these cannabinoids to KRas oncogenes that mutate in more than 90% of PC, and their effects on PD-L1, a key targe...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662796/ https://www.ncbi.nlm.nih.gov/pubmed/33126623 http://dx.doi.org/10.3390/ijms21218035 |
_version_ | 1783609479853506560 |
---|---|
author | Yang, Yang Huynh, Nhi Dumesny, Chelsea Wang, Kai He, Hong Nikfarjam, Mehrdad |
author_facet | Yang, Yang Huynh, Nhi Dumesny, Chelsea Wang, Kai He, Hong Nikfarjam, Mehrdad |
author_sort | Yang, Yang |
collection | PubMed |
description | The anti-cancer effects of cannabinoids including CBD (Cannabidiol) and THC ((−)-trans-∆9-tetrahydrocannabinol) have been reported in the case of pancreatic cancer (PC). The connection of these cannabinoids to KRas oncogenes that mutate in more than 90% of PC, and their effects on PD-L1, a key target of immune checkpoint blockade, have not been thoroughly investigated. Using cell lines and mouse models of PC, the effects of CBD and THC on cancer growth, the interaction between PC cells and a stromal cell, namely pancreatic stellate cells (PSCs), and the mechanism(s) involved were determined by cell-based assays and mouse study in vivo. CBD and THC inhibited the proliferation of PC, PSC, and PSC-stimulated PC cells. They also suppressed pancreatic tumour growth in mice. Furthermore, CBD and/or THC reduced the expression of PD-L1 by either PC or PSC cells. Knockout of p-21 activated kinase 1 (PAK1, activated by KRas) in PC and PSC cells and, in mice, dramatically decreased or blocked these inhibitory effects of CBD and/or THC. These results indicated that CBD and THC exerted their inhibitions on PC and PSC via a p-21 activated kinase 1 (PAK1)-dependent pathway, suggesting that CBD and THC suppress Kras activated pathway by targeting PAK1. The inhibition by CBD and THC of PD-L1 expression will enhance the immune checkpoint blockade of PC. |
format | Online Article Text |
id | pubmed-7662796 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-76627962020-11-14 Cannabinoids Inhibited Pancreatic Cancer via P-21 Activated Kinase 1 Mediated Pathway Yang, Yang Huynh, Nhi Dumesny, Chelsea Wang, Kai He, Hong Nikfarjam, Mehrdad Int J Mol Sci Article The anti-cancer effects of cannabinoids including CBD (Cannabidiol) and THC ((−)-trans-∆9-tetrahydrocannabinol) have been reported in the case of pancreatic cancer (PC). The connection of these cannabinoids to KRas oncogenes that mutate in more than 90% of PC, and their effects on PD-L1, a key target of immune checkpoint blockade, have not been thoroughly investigated. Using cell lines and mouse models of PC, the effects of CBD and THC on cancer growth, the interaction between PC cells and a stromal cell, namely pancreatic stellate cells (PSCs), and the mechanism(s) involved were determined by cell-based assays and mouse study in vivo. CBD and THC inhibited the proliferation of PC, PSC, and PSC-stimulated PC cells. They also suppressed pancreatic tumour growth in mice. Furthermore, CBD and/or THC reduced the expression of PD-L1 by either PC or PSC cells. Knockout of p-21 activated kinase 1 (PAK1, activated by KRas) in PC and PSC cells and, in mice, dramatically decreased or blocked these inhibitory effects of CBD and/or THC. These results indicated that CBD and THC exerted their inhibitions on PC and PSC via a p-21 activated kinase 1 (PAK1)-dependent pathway, suggesting that CBD and THC suppress Kras activated pathway by targeting PAK1. The inhibition by CBD and THC of PD-L1 expression will enhance the immune checkpoint blockade of PC. MDPI 2020-10-28 /pmc/articles/PMC7662796/ /pubmed/33126623 http://dx.doi.org/10.3390/ijms21218035 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Yang, Yang Huynh, Nhi Dumesny, Chelsea Wang, Kai He, Hong Nikfarjam, Mehrdad Cannabinoids Inhibited Pancreatic Cancer via P-21 Activated Kinase 1 Mediated Pathway |
title | Cannabinoids Inhibited Pancreatic Cancer via P-21 Activated Kinase 1 Mediated Pathway |
title_full | Cannabinoids Inhibited Pancreatic Cancer via P-21 Activated Kinase 1 Mediated Pathway |
title_fullStr | Cannabinoids Inhibited Pancreatic Cancer via P-21 Activated Kinase 1 Mediated Pathway |
title_full_unstemmed | Cannabinoids Inhibited Pancreatic Cancer via P-21 Activated Kinase 1 Mediated Pathway |
title_short | Cannabinoids Inhibited Pancreatic Cancer via P-21 Activated Kinase 1 Mediated Pathway |
title_sort | cannabinoids inhibited pancreatic cancer via p-21 activated kinase 1 mediated pathway |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662796/ https://www.ncbi.nlm.nih.gov/pubmed/33126623 http://dx.doi.org/10.3390/ijms21218035 |
work_keys_str_mv | AT yangyang cannabinoidsinhibitedpancreaticcancerviap21activatedkinase1mediatedpathway AT huynhnhi cannabinoidsinhibitedpancreaticcancerviap21activatedkinase1mediatedpathway AT dumesnychelsea cannabinoidsinhibitedpancreaticcancerviap21activatedkinase1mediatedpathway AT wangkai cannabinoidsinhibitedpancreaticcancerviap21activatedkinase1mediatedpathway AT hehong cannabinoidsinhibitedpancreaticcancerviap21activatedkinase1mediatedpathway AT nikfarjammehrdad cannabinoidsinhibitedpancreaticcancerviap21activatedkinase1mediatedpathway |